Genetic animal models of malformations of cortical development and epilepsy

Journal of Neuroscience Methods

Volumn 260, Issue , 2016, Pages 73-82

  Wong, Michael ^a   Roper, Steven N ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Focal cortical dysplasia; Heterotopia; Lissencephaly; Mice; Seizure; Tuberous sclerosis

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

AGYRIA; ALEXANDER DISEASE; ANIMAL MODEL; CORTICAL DYSPLASIA; EXPERIMENTAL EPILEPSY; GENETIC ENGINEERING; HETEROTOPIA; HUMAN; MICROGYRIA; NONHUMAN; PRIORITY JOURNAL; RAT MODEL; REVIEW; TUBEROUS SCLEROSIS; ABNORMALITIES; ANIMAL; BRAIN CORTEX; DISEASE MODEL; DRUG EFFECTS; EPILEPSY; FREEZING; GENETIC PREDISPOSITION; GENETICS; MOUSE; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PROCEDURES; RAT; RODENT; SPECIES DIFFERENCE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EPILEPSY; FREEZING; GENETIC ENGINEERING; GENETIC PREDISPOSITION TO DISEASE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MICE; NERVE NET; RATS; RODENTIA; SPECIES SPECIFICITY;

EID: 84957438983     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2015.04.007     Document Type: Review

References (89)

1. Abs E., Goorden S.M., Schreiber J., Overwater I.E., Hoogeveen-Westerveld M., Bruinsma C.F., et al. TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice. Ann Neurol 2013, 74:569-579.
2. Akakin D., Martinez-Diaz H., Chen H.X., Roper S.N. Reduced densities of parvalbumin- and somatostatin-expressing interneurons in experimental cortical dysplasia and heterotopia in early postnatal development. Epilepsy Res 2013, 104:226-233.
3. Altman J., Anderson W.J., Wright K.A. Differential radiosensitivity of stationary and migratory primitive cells in the brains of infant rats. Exp Neurol 1968, 22:52-74.
4. Aronica E., Becker A.J., Spreafico R. Malformations of cortical development. Brain Pathol (Zurich, Switzerland) 2012, 22:380-401.
5. Backman S.A., Stambolic V., Suzuki A., Haight J., Elia A., Pretorius J., et al. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 2001, 29:396-403.
6. Barkovich A.J., Guerrini R., Kuzniecky R.I., Jackson G.D., Dobyns W.B. A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012, 135:1348-1369.
7. Barkovich A.J., Millen K.J., Dobyns W.B. A developmental and genetic classification for midbrain-hindbrain malformations. Brain 2009, 132:3199-3230.
8. Bissler J.J., Kingswood J.C., Radzikowska E., Zonnenberg B.A., Frost M., Belousova E., et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2013, 381:817-824.
9. Blumcke I., Thom M., Aronica E., Armstrong D.D., Vinters H.V., Palmini A., et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011, 52:158-174.
10. Carson R.P., Van Nielen D.L., Winzenburger P.A., Ess K.C. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis 2012, 45:369-380.
11. Cheung K.M., Lam C.W., Chan Y.K., Siu W.K., Yong L. Atypical focal cortical dysplasia in a patient with Cowden syndrome. Hong Kong Med J 2014, 20:165-167.
12. Chu-Shore C.J., Major P., Camposano S., Muzykewicz D., Thiele E.A. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010, 51:1236-1241.
13. Crino P.B. Focal brain malformations: a spectrum of disorders along the mTOR cascade. Novartis Found Symp 2007, 288:260-272. [discussion 72-81].
14. Crino P.B., Nathanson K.L., Henske E.P. The tuberous sclerosis complex. N Engl J Med 2006, 355:1345-1356.
15. Cowan D., Geller L.M. Long-term pathological effects of prenatal X-irradiation on the central nervous system of the rat. J Neuropathol Exp Neurol 1960, 19:488-527.
16. Deukmedjain A.J., King M.A., Cuda C., Roper S.N. The GABAergic system of the developing neocortex has a reduced capacity to recover from in utero injury in experimental cortical dysplasia. J Neuropathol Exp Neurol 2004, 63:1265-1273.
17. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 2008, 14:843-848.
18. Feliciano D.M., Su T., Lopez J., Platel J.C., Bordey A. Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J Clin Invest 2011, 121:1596-1607.
19. Fleck M.W., Hirotsune S., Gambello M.J., Phillips-Tansey E., Suares G., Mervis R.F., et al. Hippocampal abnormalities and enhanced excitability in a murine model of human lissencephaly. J Neurosci 2000, 20:2439-2450.
20. Franz D.N., Belousova E., Sparagana S., Bebin E.M., Frost M., Kuperman R., et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 2013, 381:125-132.
21. Fu C., Cawthon B., Clinkscales W., Bruce A., Winzenburger P., Ess K.C. GABAergic interneuron development and function is modulated by the Tsc1 gene. Cereb Cortex 2012, 22:2111-2119.
22. Gleeson J.G., Allen K.M., Fox J.W., Lamperti E.D., Berkovic S., Scheffer I., et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998, 92:63-72.
23. Goorden S.M., van Woerden G.M., van der Weerd L., Cheadle J.P., Elgersma Y. Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures. Ann Neurol 2007, 62:648-655.
24. Goto J., Talos D.M., Klein P., Qin W., Chekaluk Y.I., Anderl S., et al. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci U S A 2011, 108:E1070-E1079.
25. Greenwood J.S., Wang Y., Estrada R.C., Ackerman L., Ohara P.T., Baraban S.C. Seizures, enhanced excitation, and increased vesicle number in Lis1 mutant mice. Ann Neurol 2009, 66:644-653.
26. Guerrini R., Dobyns W.B. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol 2014, 13:710-726.
27. Hauptman J.S., Mathern G.W. Surgical treatment of epilepsy associated with cortical dysplasia: 2012 update. Epilepsia 2012, 53(Suppl. 4):98-104.
28. Jansen L.A., Uhlmann E.J., Crino P.B., Gutmann D.H., Wong M. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes. Epilepsia 2005, 46:1871-1880.
29. Kassai H., Sugaya Y., Noda S., Nakao K., Maeda T., Kano M., et al. Selective activation of mTORC1 signaling recapitulates microcephaly, tuberous sclerosis, and neurodegenerative diseases. Cell Rep 2014, 7:1626-1639.
30. Kawaguchi Y., Kubota Y. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 1997, 7:476-486.
31. Kellinghaus C., Kunieda T., Ying Z., Pan A., Lüders H.O., Najm I.M. Severity of histopathologic abnormalities and in vivo epileptogenicity in the in utero radiation model of rats is dose dependent. Epilepsia 2004, 45:583-591.
32. Kerjan G., Koizumi H., Han E.B., Dube C.M., Djakovic S.N., Patrick G.N., et al. Mice lacking doublecortin and doublecortin-like kinase 2 display altered hippocampal neuronal maturation and spontaneous seizures. Proc Natl Acad Sci U S A 2009, 106:6766-6771.
33. Kitamura K., Itou Y., Yanazawa M., Ohsawa M., Suzuki-Migishima R., Umeki Y., et al. Three human ARX mutations cause the lissencephaly-like and mental retardation with epilepsy-like pleiotropic phenotypes in mice. Hum Mol Genet 2009, 18:3708-3724.
34. Kitamura K., Yanazawa M., Sugiyama N., Miura H., Iizuka-Kogo A., Kusaka M., et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 2002, 32:359-369.
35. Kondo S., Najm I., Kunieda T., Perryman S., Yacubova K., Lüders H.O. Electroencephalographic characterization of an adult rat model of radiation-induced cortical dysplasia. Epilepsia 2001, 42:1221-1227.
36. Krueger D.A., Care M.M., Holland K., Agricola K., Tudor C., Mangeshkar P., et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010, 363:1801-1811.
37. Krueger D.A., Wilfong A.A., Holland-Bouley K., Anderson A.E., Agricola K., Tudor C., et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 2013, 74:679-687.
38. Kwon C.H., Zhu X., Zhang J., Baker S.J. mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci U S A 2003, 100:12923-12928.
39. Lee J.H., Huynh M., Silhavy J.L., Kim S., Dixon-Salazar T., Heiberg A., et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012, 44:941-945.
40. Li S., Jin Z., Koirala S., Bu L., Xu L., Hynes R.O., et al. GPR56 regulates pial basement membrane integrity and cortical lamination. J Neurosci 2008, 28:5817-5826.
41. Ljungberg M.C., Sunnen C.N., Lugo J.N., Anderson A.E., D'Arcangelo G. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Mod Mech 2009, 2:389-398.
42. Lo Nigro C., Chong C.S., Smith A.C., Dobyns W.B., Carrozzo R., Ledbetter D.H. Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum Mol Genet 1997, 6:157-164.
43. Lozovaya N., Gataullina S., Tsintsadze T., Tsintsadze V., Pallesi-Pocachard E., Minlebaev M., et al. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. Nat Commun 2014, 5:4563.
44. Magri L., Cambiaghi M., Cominelli M., Alfaro-Cervello C., Cursi M., Pala M., et al. Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell 2011, 9:447-462.
45. Magri L., Cominelli M., Cambiaghi M., Cursi M., Leocani L., Minicucci F., et al. Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models. Dis Mod Mech 2013, 6:1185-1197.
46. Manent J.B., Wang Y., Chang Y., Paramasivam M., LoTurco J.J. Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder. Nat Med 2009, 15:84-90.
47. Marin-Valencia I., Guerrini R., Gleeson J.G. Pathogenetic mechanisms of focal cortical dysplasia. Epilepsia 2014, 55:970-978.
48. Marsh E., Fulp C., Gomez E., Nasrallah I., Minarcik J., Sudi J., et al. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 2009, 132:1563-1576.
49. Meikle L., Pollizzi K., Egnor A., Kramvis I., Lane H., Sahin M., et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 2008, 28:5422-5432.
50. Meikle L., Talos D.M., Onda H., Pollizzi K., Rotenberg A., Sahin M., et al. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci 2007, 27:5546-5558.
51. Mirzaa G.M., Poduri A. Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology. Am J Med Genet C Semin Med Genet 2014, 166C:156-172.
52. Normand E.A., Crandall S.R.x, Thorn C.A., Murphy E.M., Voelcker B., Browning C., et al. Temporal and mosaic Tsc1 deletion in the developing thalamus disrupts thalamocortical circuitry, neural function, and behavior. Neuron 2013, 78:895-909.
53. Nosten-Bertrand M., Kappeler C., Dinocourt C., Denis C., Germain J., Phan Dinh Tuy F., et al. Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus. PLoS ONE 2008, 3:e2473.
54. O'Rourke D.J., Twomey E., Lynch S.A., King M.D. Cortical dysplasia associated with the PTEN mutation in Bannayan Riley Ruvalcaba syndrome: a rare finding. Clin Dysmorphol 2012, 21:91-92.
55. Olivetti P.R., Maheshwari A., Noebels J.L. Neonatal estradiol stimulation prevents epilepsy in Arx model of X-linked infantile spasms syndrome. Sci Transl Med 2014, 6:220ra12.
56. Orlova K.A., Crino P.B. The tuberous sclerosis complex. Ann NY Acad Sci 2010, 1184:87-105.
57. Orlova K.A., Parker W.E., Heuer G.G., Tsai V., Yoon J., Baybis M., et al. STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest 2010, 120:1591-1602.
58. Parker W.E., Orlova K.A., Parker W.H., Birnbaum J.F., Krymskaya V.P., Goncharov D.A., et al. Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Sci Transl Med 2013, 5:182ra53.
59. Piao X., Hill R.S., Bodell A., Chang B.S., Basel-Vanagaite L., Straussberg R., et al. G protein-coupled receptor-dependent development of human frontal cortex. Science 2004, 303:2033-2036.
60. Poduri A., Evrony G.D., Cai X., Elhosary P.C., Beroukhim R., Lehtinen M.K., et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 2012, 74:41-48.
61. Poirier K., Keays D.A., Francis F., Saillour Y., Bahi N., Manouvrier S., et al. Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (TUBA1A). Hum Mutat 2007, 28:1055-1064.
62. Price M.G., Yoo J.W., Burgess D.L., Deng F., Hrachovy R.A., Frost J.D., et al. A triplet repeat expansion genetic mouse model of infantile spasms syndrome. Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci 2009, 29:8752-8763.
63. Ramos R.L., Bai J., LoTurco J.J. Heterotopia formation in rat but not mouse neocortex after RNA interference knockdown of DCX. Cereb Cortex 2006, 16:1323-1331.
64. Roper S.N., Abraham L.A., Streit W.J. Exposure to in utero irradiation produces disruption of radial glia in rats. Dev Neurosci 1997, 19:521-528.
65. Roper S.N., Gilmore R.L., Houser C.R. Experimentally induced disorders of neuronal migration produce an increased propensity for electrographic seizures in rats. Epilepsy Res 1995, 21:205-219.
66. Scheffer I.E., Heron S.E., Regan B.M., Mandelstam S., Crompton D.E., Hodgson B.L., et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 2014, 75:782-787.
67. Setkowicz Z., Klak K., Janeczko K. Long-term changes in postnatal susceptibility to pilocarpine-induced seizures in rats exposed to gamma radiation at different stages of prenatal development. Epilepsia 2003, 44:1267-1273.
68. Stottmann R.W., Donlin M., Hafner A., Bernard A., Sinclair D.A., Beier D.R. A mutation in Tubb2b, a human polymicrogyria gene, leads to lethality and abnormal cortical development in the mouse. Hum Mol Genet 2013, 22:4053-4063.
69. Stutterd C.A., Leventer R.J. Polymicrogyria: a common and heterogeneous malformation of cortical development. Am J Med Genet C Semin Med Genet 2014, 166c:227-239.
70. Sunnen C.N., Brewster A.L., Lugo J.N., Vanegas F., Turcios E., Mukhi S., et al. Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice. Epilepsia 2011, 52:2065-2075.
71. Tsai P.T., Hull C., Chu Y., Greene-Colozzi E., Sadowski A.R., Leech J.M., et al. Autistic-like behavior and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 2012, 488:647-651.
72. Uhlmann E.J., Wong M., Baldwin R.L., Bajenaru M.L., Onda H., Kwiatkowski D.J., et al. Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol 2002, 52:285-296.
73. Waltereit R., Welzl H., Dichgans J., Lipp H.P., Schmidt W.J., Weller M. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis. J Neurochem 2006, 96:407-413.
74. Way S.W., McKenna J., Mietzsch U., Reith R.M., Wu H.C., Gambello M.J. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet 2009, 18:1252-1265.
75. Way S.W., Rozas N.S., Wu H.C., McKenna J., Reith R.M., Hashmi S.S., et al. The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex. Hum Mol Genet 2012, 21:3226-3236.
76. Wong M. A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials. Expert Rev Neurother 2013, 13:657-669.
77. Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 2010, 51:27-36.
78. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 2008, 49:8-21.
79. Wong M., Ess K.C., Uhlmann E.J., Jansen L.A., Li W., Crino P.B., et al. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol 2003, 54:251-256.
80. Zeng L.H., Ouyang Y., Gazit V., Cirrito J.R., Jansen L.A., Ess K.C., et al. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex. Neurobiol Dis 2007, 28:184-196.
81. Zeng L.H., Rensing N.R., Zhang B., Gutmann D.H., Gambello M.J., Wong M. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet 2011, 20:445-454.
82. Zeng L.H., Xu L., Gutmann D.H., Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008, 63:444-453.
83. Zhou F.W., Chen H.X., Roper S.N. Balance of inhibitory and excitatory synaptic activity is altered in fast-spiking interneurons in experimental cortical dysplasia. J Neurophysiol 2009, 102:2514-2525.
84. Zhou F.W., Rani A., Martinez-Diaz H., Foster T.C., Roper S.N. Altered behavior in experimental cortical dysplasia. Epilepsia 2011, 52:2293-2303.
85. Zhou F.X., Roper S.N. Altered firing rates and patterns in interneurons in experimental cortical dysplasia. Cereb Cortex 2011, 21:1645-1658.
86. Zhou F.W., Roper S.N. Impaired hippocampal memory function and synaptic plasticity in experimental cortical dysplasia. Epilepsia 2012, 53:850-859.
87. Zhou F.W., Roper S.N. Reduced chemical and electrical connections of fast-spiking interneurons in experimental cortical dysplasia. J Neurophysiol 2014, 112:1277-1290.
88. Zhou J., Blundell J., Ogawa S., Kwon C.H., Zhang W., Sinton C., et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 2009, 29:1773-1783.
89. Zhu W.J., Roper S.N. Reduced inhibition in an animal model of cortical dysplasia. J Neurosci 2000, 20:8925-8931.